Diagnostic Ability of Volatile Organic Compounds in Digestive Cancer: A Systematic Review With Meta-Analysis.

Publication Year: 2022

DOI:
10.1177/11795549221105027

PMCID:
PMC9218909

PMID:
35754925

Journal Information

Full Title: Clin Med Insights Oncol

Abbreviation: Clin Med Insights Oncol

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Oncology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
4/6
66.7% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declaration of Conflicting Interests: The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article."

Evidence found in paper:

"Funding: The author(s) received no financial support for the research, authorship, and/or publication of this article."

Evidence found in paper:

"This systematic review was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. The protocol of this study is documented on PROSPERO (CRD42021260039). Two authors independently searched the term combination of VOCs and targeted cancer in PubMed and Ovid-Medline (updated to May 25, 2020). The details of search strategy are described in Supplemental File S2. Conclusions:: Volatile organic compounds have potential role in diagnosing GI cancer with comparatively high sensitivity, specificity, and AUC (PROSPERO registration number: CRD42021260039)."

Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025